The Use of Biomarkers for Oncology Drug Development
3rd Mar 2006, 03:32 GMT
In this report from ECCO 2005, Dr. Marc Gozlan discusses the possibilities of using biomarkers as endpoints in clinical trials. (CME) Medscape Hematology-Oncology Marc Gozlan